Angiodynamics ANGO
Angiodynamics Inc · Nasdaq · Surgical & Medical Instruments & Apparatus
Price, last 48 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| July 30, 2026 | Warren Nighan Jr SVP Quality and Regulatory | Sold | 23,370 | $14.72 | $344,006 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 11 →Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedAngioDynamics Q1 FY2027 net sales rise 6.9% to $80.9 million; Med Tech up 13.2%, FY2027 guidance reiterated, CEO transition to Eric Honroth
Entry into a material definitive agreement · Departure/appointment of directors or officers · Financial statements and exhibits
AI summary, unreviewedAngioDynamics Names Eric Honroth CEO Effective November 2, 2026, Succeeding James Clemmer After Ten Years